GlaxoSmithKline plc (NYSE: GSK) reported Q4 EPS of GBP0.22, versus GBP0.51 reported last year. Revenue for the quarter came in at GBP6.19 million, versus GBP6.91 million reported last year.

For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.